Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Biogen Inc shares valued at $17,293 were sold by Singhal Priya on Dec 09 ’24. At $157.21 per share, Singhal Priya sold 110 shares. The insider’s holdings dropped to 5,426 shares worth approximately $0.81 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Singhal Priya purchased 110 shares, netting a total of over 17,293 in proceeds.
Before that, Singhal Priya had sold 431 shares from its account. In a trade valued at $88,019, the Head of Development traded Biogen Inc shares for $204.22 each. Upon closing the transaction, the insider’s holdings decreased to 431 shares, worth approximately $0.8 million.
As published in a research note from BMO Capital Markets on December 20, 2024, Biogen Inc [BIIB] has been rated down from an Outperform to a Market perform and the price target has been revised to $164 from $230. Analysts at Stifel downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in mid December. Earlier on December 09, 2024, Jefferies downgraded its rating. Their new recommendation was “a Hold” for BIIB stock which previously was a “a Buy”.
Analyzing BIIB Stock Performance
During the last five days, there has been a surge of approximately 2.12%. Over the course of the year, Biogen Inc shares have dropped approximately -42.07%. Shares of the company reached a 52-week high of $268.30 on 01/03/24 and a 52-week low of $145.07 on 12/20/24. A 50-day SMA is recorded $165.58, while a 200-day SMA reached $200.21. Nevertheless, trading volume fell to 0.85 million shares from 0.52 million shares the previous day.
Support And Resistance Levels for Biogen Inc (BIIB)
According to the 24-hour chart, there is a support level at 148.26, which, if violated, would cause prices to drop to 146.62. In the upper region, resistance lies at 151.11. The next price resistance is at 152.32. RSI (Relative Strength Index) is 35.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.24, which suggests the price will decrease in the coming days. Percent R is at 69.36%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
